Ravinia was able to complete the transaction swiftly and thereby avoid other restructuring options.
Chicago, IL (PRWEB) June 02, 2016
Ravinia Capital LLC, a Chicago-based boutique investment bank focused on sell-side M&A for distressed middle market companies, is pleased to announce the sale of Medivative Technologies, LLC, a prominent Indiana medical device manufacturer, to Kimball Electronics Group, LLC. Ravinia Capital, in collaboration with John Kemp of Wolverine Partners, led the transaction team and completed the sale process in less than 90 days.
Due to a market recall of a key product line in late 2015, Medivative experienced rapid profitability and liquidity challenges. Once retained, Ravinia worked quickly to launch a full sales process, and marketed the Company to various distressed-focused private equity firms and strategic companies. Working closely with the Client’s other professional advisors, Ravinia was able to complete the transaction swiftly and thereby avoid other restructuring options.
The Company’s professional advisors on the transaction were:
Ravinia Capital: Tom Goldblatt, President and Ben Schmidt, Senior Analyst
Wolverine Partners: John Kemp,Managing Partner
Taft Stettinius& Hollister LLP: Michael O’Neil, Partner and John Humphrey, Partner
Hamernik, LLC: Kevin Hamernik, Managing Partner and Tyler Klaehn, Associate
About Ravinia Capital
Ravinia Capital LLC is a Chicago-based boutique investment bank that serves as transactional advisors to middle market clients on capital market initiatives including sales, mergers and acquisitions, and refinancing. It helps its clients understand their funding needs, sources the correct funding opportunities or buyer, and then structures and closes transactions. With its focus on middle market companies, Ravinia Capital seeks to address the unique complexities that are often found in privately-held or family-owned businesses. Please visit our website at http://www.raviniacapitalllc.com/ or email info(at)raviniacapitalllc.com for more information.